SPRUCE BIOSCIENCES, INC. - Common Stock, par value $0.0001 per share (SPRB)
Historical Holders from Q4 2020 to Q3 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Symbol
-
SPRB on Nasdaq
-
Shares outstanding
-
41,893,357
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares as of 30 Sep 2025
-
0
-
Holdings value
-
$0
-
Share change
-
-2,046,828
-
Value change
-
-$146,574
-
Average sells %
-
-0%
-
Number of holders
-
0
-
Price from insider filings
-
$148.16
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of SPRUCE BIOSCIENCES, INC. - Common Stock, par value $0.0001 per share (SPRB) based on Schedule 13D/G filings
As of 30 Sep 2025, SPRUCE BIOSCIENCES, INC. - Common Stock, par value $0.0001 per share (SPRB) has 0 institutional shareholders filing 13F forms.
They hold 0 shares
of 41,893,357 outstanding shares (0%)
.
Institutional Holders of SPRUCE BIOSCIENCES, INC. - Common Stock, par value $0.0001 per share (SPRB) across Reporting Periods
| Period |
Reported Shares, Excl. Options |
Value, Excl. Options |
Value Change |
Puts Notional Value |
Calls Notional Value |
Price |
Investors |
|
2025 Q3
|
0 |
$0 |
-$146,574 |
|
|
|
0 |
|
2025 Q2
|
2,046,828 |
$146,574 |
-$2,433,360 |
|
|
$0.0725 |
3 |
|
2025 Q1
|
10,436,798 |
$3,024,802 |
-$321,461 |
|
|
$0.2901 |
30 |
|
2024 Q4
|
11,164,918 |
$4,686,111 |
+$183,106 |
$0 |
$0 |
$0.4200 |
30 |
|
2024 Q3
|
13,598,951 |
$6,399,774 |
-$1,537,557 |
$522 |
$7,860 |
$0.4749 |
29 |
|
2024 Q2
|
16,573,655 |
$8,601,460 |
-$1,330,613 |
$30,726 |
$13,955 |
$0.5177 |
36 |
|
2024 Q1
|
17,968,530 |
$14,122,228 |
-$48,624,275 |
$37,804 |
$38,509 |
$0.7859 |
49 |
|
2023 Q4
|
32,256,406 |
$94,395,094 |
-$2,945,462 |
|
|
$2.93 |
40 |
|
2023 Q3
|
31,887,003 |
$71,977,719 |
-$177,344 |
|
|
$2.26 |
41 |
|
2023 Q2
|
31,965,361 |
$68,724,289 |
-$3,880,411 |
|
|
$2.15 |
39 |
|
2023 Q1
|
33,758,488 |
$74,521,749 |
+$39,533,296 |
|
|
$2.21 |
44 |
|
2022 Q4
|
18,240,239 |
$19,982,773 |
-$50,960 |
|
|
$1.10 |
30 |
|
2022 Q3
|
18,044,145 |
$24,737,766 |
+$2,300,031 |
|
|
$1.37 |
30 |
|
2022 Q2
|
16,375,954 |
$28,493,706 |
-$1,235,202 |
|
|
$1.74 |
30 |
|
2022 Q1
|
17,089,653 |
$34,351,000 |
-$1,832,781 |
|
|
$2.01 |
41 |
|
2021 Q4
|
15,551,600 |
$69,378,000 |
-$13,260,253 |
|
|
$4.46 |
48 |
|
2021 Q3
|
17,491,470 |
$105,151,000 |
-$12,936,894 |
|
|
$6.01 |
42 |
|
2021 Q2
|
17,947,848 |
$201,197,000 |
+$10,306,769 |
|
|
$11.21 |
40 |
|
2021 Q1
|
16,719,781 |
$277,547,000 |
-$943,154 |
|
|
$16.60 |
39 |
|
2020 Q4
|
16,730,339 |
$406,705,000 |
+$406,704,983 |
|
|
$24.31 |
44 |